Karin Purshouse

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

Lennard Y. W. Lee, Jean‐Baptiste Cazier, Vasileios Angelis et al. · The Lancet · 2020 · 1.1K citations · Full text

Covid-19 Mortality, Epidemiology, Cancer Epidemiology +12

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey et al. · The Lancet Oncology · 2020 · 599 citations · Full text

Primary Tumour Subtype, Epidemiology, Cancer Epidemiology +11

2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity

Parker L. Sulkowski, Christopher D. Corso, Nathaniel D. Robinson et al. · Science Translational Medicine · 2017 · 550 citations

Genetics, Molecular Biology, Molecular Genetics +19

The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer

Leonardo Lisbôa da Motta, Ioanna Ledaki, Karin Purshouse et al. · Oncogene · 2016 · 141 citations · Full text

The UK Coronavirus Cancer Monitoring Project: protecting patients with cancer in the era of COVID-19

Iris Anil, Roland Arnold, Sam Benkwitz-Beford et al. · The Lancet Oncology · 2020 · 65 citations · Full text